$Cassava Sciences (SAVA.US)$ • $126.3 Million In Total Gross...
$Cassava Sciences(SAVA.US$ • $126.3 Million In Total Gross Proceeds from Warrant Distribution.
• Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.
• Over 735 Patients Have Completed a Phase 3 Trial of Simufilam.
• Over 1,900 Patients with Alzheimer’s Disease Are Randomized in Phase 3 Trials of Simufilam.
• Over 735 Patients Have Completed a Phase 3 Trial of Simufilam.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
